Cargando…
Molecular MR Imaging of Prostate Cancer
This review summarizes recent developments regarding molecular imaging markers for magnetic resonance imaging (MRI) of prostate cancer (PCa). Currently, the clinical standard includes MR imaging using unspecific gadolinium-based contrast agents. Specific molecular probes for the diagnosis of PCa cou...
Autores principales: | Kader, Avan, Brangsch, Julia, Kaufmann, Jan O., Zhao, Jing, Mangarova, Dilyana B., Moeckel, Jana, Adams, Lisa C., Sack, Ingolf, Taupitz, Matthias, Hamm, Bernd, Makowski, Marcus R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7822017/ https://www.ncbi.nlm.nih.gov/pubmed/33375045 http://dx.doi.org/10.3390/biomedicines9010001 |
Ejemplares similares
-
Assessment of Albumin ECM Accumulation and Inflammation as Novel In Vivo Diagnostic Targets for Multi-Target MR Imaging
por: Möckel, Jana, et al.
Publicado: (2021) -
Visualization and Quantification of the Extracellular Matrix in Prostate Cancer Using an Elastin Specific Molecular Probe
por: Kader, Avan, et al.
Publicado: (2021) -
Iron Oxide Nanoparticles for Visualization of Prostate Cancer in MRI
por: Kader, Avan, et al.
Publicado: (2022) -
Collagen-Specific Molecular Magnetic Resonance Imaging of Prostate Cancer
por: Kader, Avan, et al.
Publicado: (2022) -
Dynamic Contrast-Enhanced MRI of Prostate Lesions of Simultaneous [(68)Ga]Ga-PSMA-11 PET/MRI: Comparison between Intraprostatic Lesions and Correlation between Perfusion Parameters
por: Zhao, Jing, et al.
Publicado: (2021)